This educational activity will review the function of the tear film in maintaining a healthy ocular surface and evaluate clinical trial data for agents under development for the treatment of meibomian gland dysfunction–associated dry eye disease.

This educational activity is intended to help clinicians identify patients with thyroid eye disease who require intervention for elevated blood glucose levels prior to treatment for thyroid eye disease with the insulin-like growth factor 1 receptor antagonist teprotumumab.

This educational activity aims to equip oculoplastic surgeons and ophthalmologists with advanced knowledge of the diagnosis, individualized treatment planning, and management of thyroid eye disease, highlighting the importance of a collaborative, multidisciplinary care team.

Following this educational activity, clinicians will be able to identify opportunities for early referral of patients with neovascular age-related macular degeneration and choose appropriate strategies for comanagement of patients with retinal disease.